| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/06/2001 | WO2001092534A1 Biological materials and methods for use in the prevention or treatment of infections |
| 12/06/2001 | WO2001092533A1 Anti-listeria bacteriocin |
| 12/06/2001 | WO2001092532A1 Cloning and sequencing of dac g5 allergen of dactylis glomerata pollen, preparation and use thereof |
| 12/06/2001 | WO2001092531A1 Cloning and sequencing the dac g1 allergen of dactylis glomerata pollen, preparation and use thereof |
| 12/06/2001 | WO2001092530A1 Nucleic acid molecule comprising a nucleic acid sequence coding for an sdf-1 gamma chemokine, a neuropeptide precursor or at least one neuropeptide |
| 12/06/2001 | WO2001092527A2 Regulators of apoptosis |
| 12/06/2001 | WO2001092526A1 Human kcnq5 potassium channel, methods and compositions thereof |
| 12/06/2001 | WO2001092525A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 12/06/2001 | WO2001092524A2 Myosin-like gene expressed in human heart and muscle |
| 12/06/2001 | WO2001092523A2 Human polynucleotides and polypeptides encoded thereby |
| 12/06/2001 | WO2001092522A2 Human fgf-20 nucleic acids and polypeptides |
| 12/06/2001 | WO2001092520A1 Modified chemokine receptor ccr-3 and assay |
| 12/06/2001 | WO2001092519A1 A novel polypeptide, a dynein light-moderate chain 20 and the polynucleotide encoding the polypeptide |
| 12/06/2001 | WO2001092518A1 A novel polypeptide, a human ccr4 relative protein 9.5 and the polynucleotide encoding the polypeptide |
| 12/06/2001 | WO2001092517A1 A novel polypeptide, a human transformer-2-beta protein 29.15 and the polynucleotide encoding the polypeptide |
| 12/06/2001 | WO2001092516A1 A NOVEL POLYPEPTIDE, A RIBOSOME s19e PROTEIN 13 AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE |
| 12/06/2001 | WO2001092515A1 A novel polypeptide, a human transcription factor 29.26 and the polynucleotide encoding the polypeptide |
| 12/06/2001 | WO2001092514A1 A novel polypeptide-human interleukin-13 (il-13) receptor 11 and the polynucleotide encoding said polypeptide |
| 12/06/2001 | WO2001092505A2 A method for producing a multifunctional lysyl hydroxylases with glycosyltransferase activity |
| 12/06/2001 | WO2001092504A2 Triacylglycerol lipases from arabidopsis thaliana |
| 12/06/2001 | WO2001092503A2 Regulation of human calcium-independent alpha-latro-toxin-like g protein-coupled receptor |
| 12/06/2001 | WO2001092499A1 NUCLEIC ACID MOLECULES ENCODING A PROTEIN INTERACTING WITH Ser/Thr KINASE Akt |
| 12/06/2001 | WO2001092498A1 Novel laccase enzyme and the gene encoding the enzyme |
| 12/06/2001 | WO2001092496A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/06/2001 | WO2001092485A1 DNAs ENCODING MAMMALIAN HISTAMINE RECEPTOR OF THE H4 SUBTYPE |
| 12/06/2001 | WO2001092474A1 Alpha (2) macroglobulin receptors as a heat shock protein receptor and uses thereof |
| 12/06/2001 | WO2001092471A1 Heavy-metal binding bacteria and their use in detoxification of heavy metal-contaminated media |
| 12/06/2001 | WO2001092470A2 Dna expression vectors and methods of use |
| 12/06/2001 | WO2001092469A2 Phosphorylated polypeptides and uses related thereto |
| 12/06/2001 | WO2001092468A2 Novel compositions for the expression of the human peptide histidine transporter 1 and methods of use thereof |
| 12/06/2001 | WO2001092339A1 Molecular marker for mitosis |
| 12/06/2001 | WO2001092337A2 Soluble ctla4 mutant molecules and uses thereof |
| 12/06/2001 | WO2001092336A1 Lactoferrin polypeptides from h. pylori and vaccine compositions thereof |
| 12/06/2001 | WO2001092335A1 Protein complex crystals, structural coordinates and utilization of the structural coordinates |
| 12/06/2001 | WO2001092334A1 Glucose dependent release of insulin from glucose sensing insulin derivatives |
| 12/06/2001 | WO2001092333A2 Use of adnf for enhancing learning and memory |
| 12/06/2001 | WO2001092332A1 Feline hepatocyte growth factor |
| 12/06/2001 | WO2001092331A2 Compositions and methods for the treatment of immune related diseases |
| 12/06/2001 | WO2001092330A2 Use of acrp30 globular head to promote increases in muscle mass and muscle differentiation |
| 12/06/2001 | WO2001092329A1 A NOVEL POLYPEPTIDE - α-SUBUNIT 9.9 OF ATP SYNTHASE AND A POLYNUCLEOTIDE ENCODING THE SAME |
| 12/06/2001 | WO2001092328A1 A novel polypeptide -human tre oncogene 10.78 and a polynucleotide sequence encoding the same |
| 12/06/2001 | WO2001092327A1 A novel polypeptide - centrosomal nek-2-binding protein 111 and a polynucleotide encoding the same |
| 12/06/2001 | WO2001092325A1 A novel polypeptide human-zinc-finger protein 13 and a polynucleotide encoding the same |
| 12/06/2001 | WO2001092324A1 A novel polypeptide -human basonuclin 10.78 and a polynucleotide sequence encoding the same |
| 12/06/2001 | WO2001092322A1 Use of collagen of aquatic origin for producing support designed for tissue engineering, and resulting supports and biomaterials |
| 12/06/2001 | WO2001092321A2 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes |
| 12/06/2001 | WO2001092320A2 Use a high-molecular-weight extracellular haemoglobin as blood substitute |
| 12/06/2001 | WO2001092319A1 A NOVEL POLYPEPTIDE-HOMO TNF α RECEPTOR 19.68 AND POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE |
| 12/06/2001 | WO2001092318A1 A novel polypeptide, a kringle protein 14 and the polynucleotide encoding the polypeptide |
| 12/06/2001 | WO2001092316A1 A novel polypeptide, a phytochrome 12 and the polynucleotide encoding the polypeptide |
| 12/06/2001 | WO2001092315A1 A novel polypeptide, a human splicing protein 10.56 and the polynucleotide encoding the polypeptide |
| 12/06/2001 | WO2001092314A1 A novel polypeptide, a human organic anion transporting polypeptide 10 and the polynucleotide encoding the polypeptide |
| 12/06/2001 | WO2001092313A2 Methods for isolating and using fungal hemolysins |
| 12/06/2001 | WO2001092312A1 Peptide substrate identified by type bont/b botulinus toxin and use thereof for assaying and/or detecting said toxin or corresponding inhibitors |
| 12/06/2001 | WO2001092311A2 Convergent combinatory peptide libraries and their use for vaccination against hepatitis c virus |
| 12/06/2001 | WO2001092309A2 Human beta-defensin-3 (hbd-3), a highly cationic beta-defensin antimicrobial peptide |
| 12/06/2001 | WO2001092308A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 12/06/2001 | WO2001092307A2 Therapeutic compounds for ovarian cancer |
| 12/06/2001 | WO2001092306A2 Therapeutic compounds for ovarian cancer |
| 12/06/2001 | WO2001092305A2 Mammalian transforming growth factor beta-10 |
| 12/06/2001 | WO2001092304A2 Transporters and ion channels |
| 12/06/2001 | WO2001092303A2 Human ion channels |
| 12/06/2001 | WO2001092302A2 Human cyslt2 nucleic acids, polypeptides, and uses thereof |
| 12/06/2001 | WO2001092301A2 Placc, a novel human c-c chemokine isolated from placenta |
| 12/06/2001 | WO2001092300A2 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level |
| 12/06/2001 | WO2001092299A2 Adenovirus particles with mutagenized fiber proteins |
| 12/06/2001 | WO2001092298A2 MUTEINS OF A CHAIN OF A PROTEIN FROM THE SUPERFAMILY OF GROWTH FACTOR TGF-$g(b) |
| 12/06/2001 | WO2001092297A2 Regulation of human lgr4-like g protein-coupled receptor |
| 12/06/2001 | WO2001092296A2 Regulation of human isotocin-like g protein-coupled receptor |
| 12/06/2001 | WO2001092295A2 Ligands for cd21 and compositions thereof for modulating immune responses |
| 12/06/2001 | WO2001092294A2 Therapeutic anti-melanoma compounds |
| 12/06/2001 | WO2001092292A2 Ghrelin analogs |
| 12/06/2001 | WO2001092291A2 Antibody and t-cell receptor libraries |
| 12/06/2001 | WO2001092286A1 A novel peptide---human octamer binding protein 48 and the polynucleotide coding this novel peptide |
| 12/06/2001 | WO2001092278A2 Haplotypes of the rlbp1 gene |
| 12/06/2001 | WO2001091814A2 Polyubiquitin based hydrogel and uses thereof |
| 12/06/2001 | WO2001091787A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 12/06/2001 | WO2001091781A2 Thrombospondin type 1 repeat polypeptides |
| 12/06/2001 | WO2001091780A1 Neuroprotective peptides |
| 12/06/2001 | WO2001091700A2 Composition and method for enhancing elasticity of tissue |
| 12/06/2001 | WO2001091698A2 Genetically-engineered mhc molecules |
| 12/06/2001 | WO2001091548A2 Mice heterozygous for wfs1 gene as mouse models for depression |
| 12/06/2001 | WO2001091536A2 Genetic vaccine that mimics natural viral infection and induces long-lasting immunity to pathogens |
| 12/06/2001 | WO2001068805A8 Human olfactory receptors and genes encoding same |
| 12/06/2001 | WO2001064922A3 Heterologous expression of neisserial proteins |
| 12/06/2001 | WO2001060837A3 Polypeptoid pulmonary surfactants |
| 12/06/2001 | WO2001057271A8 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human breast and bt 474 cells |
| 12/06/2001 | WO2001057216A3 Method for the production of a protein |
| 12/06/2001 | WO2001055387A8 Nucleic acids, proteins, and antibodies |
| 12/06/2001 | WO2001055313A8 Nucleic acids, proteins, and antibodies |
| 12/06/2001 | WO2001055167A8 Nucleic acids, proteins, and antibodies |
| 12/06/2001 | WO2001053500A8 Methods and materials relating to stem cell growth factor-like poypeptides and polynucleotides |
| 12/06/2001 | WO2001053351A3 Apoptin bindendes protein |
| 12/06/2001 | WO2001052875A8 Vegf-d/vegf-c/vegf peptidomimetic inhibitor |
| 12/06/2001 | WO2001049717A3 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or t cell subset activity by modulation of xbp-1 activity |
| 12/06/2001 | WO2001048183A3 Improvements relating to double-stranded rna inhibition |
| 12/06/2001 | WO2001046225A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 12/06/2001 | WO2001046224A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 12/06/2001 | WO2001040273A3 Transgenic zebra fish embryo model for hematopoiesis and lymphoproliferative disorders |
| 12/06/2001 | WO2001039796A3 Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases |